AEON (AEON Biopharma) Insider Ownership: 27.26 % (As of Aug. 23, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AEON AEON Biopharma Inc AEON
23 GF Score
Price $0.19
! 2 Warning Signs
View Full Analysis

What is AEON Biopharma Insider Ownership?

AEON Biopharma AEON -0.52% 23 Insider Ownership is 27.26 % as of Aug. 23, 2026. GuruFocus rates AEON with a GF Score™ of 23/100. The stock has 2 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, AEON Biopharma's insider ownership is 27.26%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, AEON Biopharma's Institutional Ownership is 10.80%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, AEON Biopharma's Float Percentage Of Total Shares Outstanding is 75.32%.

AEON Biopharma Insider Ownership Historical Data

* Premium members only.

The historical data trend for AEON Biopharma's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AEON Biopharma Insider Ownership Chart

AEON Biopharma Historical Data

The historical data trend for AEON Biopharma can be seen below:

2025-07-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30 2026-07-31
Insider Ownership 16.58 16.10 16.10 16.10 16.10 7.80 19.26 41.53 45.76 27.26
AEON
23GF Score
AEON Biopharma Inc AEON
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AEON Biopharma Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 27.26 % mean?
AEON Biopharma (AEON) has a Insider Ownership of 27.26 % as of Aug. 23, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on AEON Biopharma and its competitors.
Is AEON Biopharma's Insider Ownership too high?
AEON Biopharma's current Insider Ownership is 27.26 %. Overall, AEON Biopharma has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does AEON Biopharma's Insider Ownership compare to XCUR and PBM?
AEON Biopharma's Insider Ownership of 27.26 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on AEON Biopharma and its competitors. AEON Biopharma's current Insider Ownership is 27.26 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AEON Biopharma stock overvalued right now?
AEON Biopharma (AEON) has a current Insider Ownership of 27.26 %. The current Insider Ownership is 27.26 %. AEON Biopharma's overall GF Score™ is 23/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For AEON Biopharma (AEON), the current Insider Ownership is 27.26 % as of Aug. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AEON Biopharma Business Description

Address 5 Park Plaza, Suite 1750, Irvine, CA, USA, 92614
AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.
23GF Score

Get the complete analysis for AEON

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.19
Price